Cargando…
Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694729/ https://www.ncbi.nlm.nih.gov/pubmed/26696027 http://dx.doi.org/10.5009/gnl15576 |
| _version_ | 1782407508861648896 |
|---|---|
| author | Paik, Yong-Han |
| author_facet | Paik, Yong-Han |
| author_sort | Paik, Yong-Han |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4694729 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46947292016-01-20 Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis Paik, Yong-Han Gut Liver Editorial Editorial Office of Gut and Liver 2016-01 2016-01-15 /pmc/articles/PMC4694729/ /pubmed/26696027 http://dx.doi.org/10.5009/gnl15576 Text en Copyright © 2016 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Paik, Yong-Han Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title | Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title_full | Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title_fullStr | Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title_full_unstemmed | Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title_short | Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis |
| title_sort | reappraisal of antihypertensive medicine doxazosin and carvedilol as a potential therapeutic for hepatic fibrosis |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694729/ https://www.ncbi.nlm.nih.gov/pubmed/26696027 http://dx.doi.org/10.5009/gnl15576 |
| work_keys_str_mv | AT paikyonghan reappraisalofantihypertensivemedicinedoxazosinandcarvedilolasapotentialtherapeuticforhepaticfibrosis |